Effectiveness and tolerability of an emollient ‘plus’ formulation in patients with xerosis or atopic dermatitis: results of a real-world observational study conducted in the United Kingdom

F. Aslanian, C. Kasparis, D. Kerob, L. Gayford, J. Whyte, S. Burgess, H. Alkaissi

  • 10min
  • Oct. 2023
  • Supported by
  • La Roche-Posay
EADV Image

INTRODUCTION & OBJECTIVES


Emollients are recommended as basic skin care in patients with any severity of atopic dermatitis (AD).1

Emollient ‘plus’ are emollients that contain active ingredients that can improve eczema lesions and influence the skin microbiome of patients with AD.2

The aim of this study was to assess the impact of an Emollient ‘plus’ on symptom management and health-related quality of life (HRQoL) in patients with xerosis, including those with AD.